Winston J. Churchill - 31 Aug 2021 Form 4 Insider Report for Baudax Bio, Inc.

Role
Director
Signature
/s/ Richard S. Casten, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
31 Aug 2021
Net transactions value
+$62,930
Form type
4
Filing time
31 Aug 2021, 17:11:30 UTC
Previous filing
08 Jun 2021
Next filing
01 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BXRX Common Stock Purchase $62,930 +100,000 +64% $0.6293 257,185 31 Aug 2021 Direct
holding BXRX Common Stock 6,500 31 Aug 2021 By Family Partnership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.